In addition, IL-6 interacts with both epidermal growth factor receptor (EGFR) to promote immunosuppressive microenvironment by inducing myeloid-derived suppressor cells (MDSC) and the vascular endothelial growth factor receptor (VEGFR) to drive tumor-induced angiogenesis in EC (21, 22). Here, EGFR is linked to neoplasm.